Robert Gold, MD
Pediatric Ophthalmology and Strabismus Specialist · Maitland, FLNPI 1093753824
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (41.1%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Luminopia, Inc. at 41.1% of the total. 2025 is the largest year on record at $1,522, more than ten times the $30 reported in 2019.
Across 32 payments — averaging $106.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Luminopia, Inc.$1K
- Natus Medical Incorporated$1K
- Amgen$561
- Sun Pharmaceutical Industries Inc.$25
- Bausch & Lomb Americas Inc.$23
- Carl Zeiss Meditec AG$19
- plus $46 from 3 others
What the payments were for
- Consulting fees$1,40041%
- Speaking & faculty fees$1,33639%
- Food & beverage$65419%
- Gifts$191%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Luminopia, Inc. | 1 | $1,400 |
| Natus Medical Incorporated | 1 | $1,336 |
| Amgen(2 entities) | 24 | $561 |
| Sun Pharmaceutical Industries Inc. | 1 | $25 |
| Bausch & Lomb Americas Inc. | 1 | $23 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Aerie Pharmaceuticals, Inc. | 1 | $16 |
| Alcon | 1 | $15 |
| Spark Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Luminopia$1,400
- TEPEZZA$125
How this compares
Too few pediatric ophthalmology and strabismus specialist providers in Floridato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 18 | $226 |
Paid to pharmacies, not to this prescriber.
Other pediatric ophthalmology and strabismus specialist in Maitland
- Louis BlumenfeldMaitland$2K
- Vikisha HazariwalaMaitland$1K
- Robert HeredMaitland$211
- Rebecca AdamsMaitland$41
- Isabella HerreraMaitland$23
- Austin BachHollywood$12K
- Dawn DussPonte Vedra Beach$9K
- Mariana Abi KaramMiami$2K
- Scott SilvermanBradenton$908
- Megha PansaraTampa$310
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.